Literature DB >> 17046744

Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain.

Basanagouda M Patil1, Nagaraj M Kulkarni, Banappa S Unger.   

Abstract

In the present study, we examined the effect of olanzapine on weight gain, systolic blood pressure and metabolic changes in rats. Female Sprague Dawley rats were treated with either vehicle or olanzapine (1 and 2 mg/kg i.p, twice daily) for 20 days. Body weight, food and water intake, systolic blood pressure, plasma glucose, insulin and lipid were measured. Olanzapine (1 and 2 mg/kg) significantly increased the body weight and systolic blood pressure. Whereas, food intake and plasma insulin and insulin resistance index, were elevated only at 1 mg/kg. In conclusion, olanzapine induced weight gain in rats is associated with elevation of systolic blood pressure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046744     DOI: 10.1016/j.ejphar.2006.09.009

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Effect of alpha-mangostin on olanzapine-induced metabolic disorders in rats.

Authors:  Alireza Ardakanian; Mahboobeh Ghasemzadeh Rahbardar; Farzaneh Omidkhoda; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

2.  Effects of clozapine administration on body weight, glucose tolerance, blood glucose concentrations, plasma lipids, and insulin in male C57BL/6 mice: A parallel controlled study.

Authors:  Hai-Yan Yuan; Hai-Xia Liang; Guang-Rong Liang; Gui-Xiang Zhang; Huan-De Li
Journal:  Curr Ther Res Clin Exp       Date:  2008-04

Review 3.  Cardiometabolic effects of psychotropic medications.

Authors:  Oluchi Abosi; Sneha Lopes; Samantha Schmitz; Jess G Fiedorowicz
Journal:  Horm Mol Biol Clin Investig       Date:  2018-01-10

4.  An evaluation of the effects of the novel antipsychotic drug lurasidone on glucose tolerance and insulin resistance: a comparison with olanzapine.

Authors:  Claire Wu; Jessica Yuen; Heidi N Boyda; Ric M Procyshyn; Cathy K Wang; Yahya I Asiri; Catherine C Y Pang; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

5.  Effect of safranal, a constituent of saffron, on olanzapine (an atypical antipsychotic) induced metabolic disorders in rat.

Authors:  Sara Malekzadeh; Mahmood Reza Heidari; Bibi Marjan Razavi; Maryam Rameshrad; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2019-12       Impact factor: 2.699

6.  Metabolic side-effects of the novel second-generation antipsychotic drugs asenapine and iloperidone: a comparison with olanzapine.

Authors:  Heidi N Boyda; Ric M Procyshyn; Catherine C Y Pang; Erin Hawkes; Daniel Wong; Chen Helen Jin; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

7.  Beneficial effect of Zingiber officinale on olanzapine-induced weight gain and metabolic changes.

Authors:  Mrityunjaya B Ullagaddi; B M Patil; Pukar Khanal
Journal:  J Diabetes Metab Disord       Date:  2021-01-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.